The global pandemic has brought about a paradigm shift in the US as far as manufacturing and the supply chain is concerned. Manufacturers are now forced to rethink their excessive reliability on foreign suppliers as there is a dearth in delivery. Companies are now struggling to meet up with customers’ orders and are now looking inwards to meet up with deadlines. Reshoring has been supported by the US government and companies that took advantage of this unique circumstance are already seeing good results.
Key Takeaways:
- The coronavirus pandemic has thrown a number of supply chains into crisis.
- One proposed solution is to bring more manufacturing back to the US, so supply chains aren’t dependent on international businesses.
- The medical and pharmaceutical industries are particularly suited for being brought back to purely domestic manufacturing.
“In 2017, President Donald J. Trump signed an executive order tasking a Defense Department Interagency Task Force to assess and strengthen manufacturing and defense supply chain resiliency, including machine tools and industrial controls.”
